Literature DB >> 25949895

The ins and outs of osteopontin.

Claudia Chiodoni1, Sabina Sangaletti1, Claudio Tripodo2, Mario P Colombo1.   

Abstract

The continuous remodeling of progressing tumors demands non-physiologic production of extracellular matrix (ECM) proteins. Among them, osteopontin (OPN) has been largely involved in tumor progression and metastasis. We have recently discovered a new mechanism for OPN in the metastatic spread of mammary carcinoma providing local immunosuppression at the seeding site.

Entities:  

Keywords:  metastasis; myeloid-derived suppressor cells; osteopontin

Year:  2015        PMID： 25949895      PMCID： PMC4404798          DOI： 10.4161/2162402X.2014.978711

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN： 2162-4011            Impact factor:   8.110


  10 in total

1.  Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity.

Authors:  S Ashkar; G F Weber; V Panoutsakopoulou; M E Sanchirico; M Jansson; S Zawaideh; S R Rittling; D T Denhardt; M J Glimcher; H Cantor
Journal:  Science       Date:  2000-02-04       Impact factor: 47.728

2.  Measurement of myeloid cell immune suppressive activity.

Authors:  Luigi Dolcetti; Elisa Peranzoni; Vincenzo Bronte
Journal:  Curr Protoc Immunol       Date:  2010-11

3.  The terminology issue for myeloid-derived suppressor cells.

Authors:  Dmitry I Gabrilovich; Vincenzo Bronte; Shu-Hsia Chen; Mario P Colombo; Augusto Ochoa; Suzanne Ostrand-Rosenberg; Hans Schreiber
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

Review 4.  Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis.

Authors:  Claudia Chiodoni; Mario P Colombo; Sabina Sangaletti
Journal:  Cancer Metastasis Rev       Date:  2010-06       Impact factor: 9.264

Review 5.  Coordinated regulation of myeloid cells by tumours.

Authors:  Dmitry I Gabrilovich; Suzanne Ostrand-Rosenberg; Vincenzo Bronte
Journal:  Nat Rev Immunol       Date:  2012-03-22       Impact factor: 53.106

6.  Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host.

Authors:  Bo Huang; Ping-Ying Pan; Qingsheng Li; Alice I Sato; David E Levy; Jonathan Bromberg; Celia M Divino; Shu-Hsia Chen
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

7.  Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells.

Authors:  Mari L Shinohara; Linrong Lu; Jing Bu; Miriam B F Werneck; Koichi S Kobayashi; Laurie H Glimcher; Harvey Cantor
Journal:  Nat Immunol       Date:  2006-04-09       Impact factor: 25.606

8.  Serial plasma osteopontin levels have prognostic value in metastatic breast cancer.

Authors:  Vivien H C Bramwell; Gordon S Doig; Alan B Tuck; Sylvia M Wilson; Katia S Tonkin; Anna Tomiak; Francisco Perera; Theodore A Vandenberg; Ann F Chambers
Journal:  Clin Cancer Res       Date:  2006-06-01       Impact factor: 12.531

9.  Osteopontin shapes immunosuppression in the metastatic niche.

Authors:  Sabina Sangaletti; Claudio Tripodo; Sara Sandri; Ilaria Torselli; Caterina Vitali; Chiara Ratti; Laura Botti; Alessia Burocchi; Rossana Porcasi; Andrea Tomirotti; Mario P Colombo; Claudia Chiodoni
Journal:  Cancer Res       Date:  2014-07-17       Impact factor: 12.701

10.  Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells.

Authors:  Mari L Shinohara; Hye-Jung Kim; June-Ho Kim; Virgilio A Garcia; Harvey Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-14       Impact factor: 11.205
  10 in total
  2 in total

1.  Lack of galectin-1 exacerbates chronic hepatitis, liver fibrosis, and carcinogenesis in murine hepatocellular carcinoma model.

Authors:  Tamara Potikha; Orit Pappo; Lina Mizrahi; Devorah Olam; Sebastián M Maller; Gabriel A Rabinovich; Eithan Galun; Daniel S Goldenberg
Journal:  FASEB J       Date:  2019-03-21       Impact factor: 5.834

2.  WDR5-H3K4me3 epigenetic axis regulates OPN expression to compensate PD-L1 function to promote pancreatic cancer immune escape.

Authors:  Chunwan Lu; Zhuoqi Liu; John D Klement; Dafeng Yang; Alyssa D Merting; Dakota Poschel; Thomas Albers; Jennifer L Waller; Huidong Shi; Kebin Liu
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.